Helicobacter pylori

The American Journal of Gastroenterology

Volumn 89, Issue , 1994, Pages s116-s128

  Marshall, Barry J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIAL TOXIN; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

BACTERIAL INFECTION; BACTERIAL VIRULENCE; CARCINOGENESIS; CONFERENCE PAPER; DISEASE TRANSMISSION; DUODENUM ULCER; GASTROSCOPY; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; IMMUNIZATION; PATHOGENICITY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMACH ULCER;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; PROGNOSIS;

EID: 0027931293     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1994.tb09231.x     Document Type: Review

References (95)

1. Gastric bacteria other than Helicobacter pylori
2. Medium supplementation for growth of Campylobacter pyloridis
3. The phylogenetic position of Helicobacter nemestrinae
4. Campytobacter pylori virulence factors in gnotobiotic piglets
5. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis
6. Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: A potential model for gastritis in man
7. Immunization against gastric Helieobacter infection in a mouse/Helicobacter felis model
8. Isolation of Helicobacter pvlori from human faeces
9. Isolation of Heli‐ cobacter pylori from patients in the UK: Implications for treatment
10. Dental plaque: A permanent reservoir of Heticobacter pvlori?
11. Examination of human stomach biopsies, saliva, and dental plaque for Campvlobacter pylori
12. Absence of Helicobacter pvlori in dental plaques in Helicobacter pvlori positive dyspeptic patients
13. Childhood living conditions and Helicobacter pylori seropositivity in adult life
14. Water source as risk factor for Helicobacter pylori infection in Peruvian children
15. Patient‐to‐patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy
16. Acute Helicobacter pylori infection: Clinical features, local and systemic immune response, gastric mueosal histology, and gastric juice ascorbic acid concentrations
17. Attempt to fulfil Koch's postulates for pyloric Campylobacter
18. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH
19. Epidemic gastritis with hypochlorhydria
20. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists
21. Helicobacter pylori infection and the risk of gastric carcinoma
22. Seroepidemiology of Heticobacter pylori infection in India. Comparison of developing and developed countries
23. Seroepidemiology of Campvlobacter pylori infection In various populations
24. Campylobacter pyloridis and gastritis: Association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium
25. Urea protects Heticobacter (Campylobacter) pylori from the bactericidal effect of acid
26. Generation of ammonia and mueosal lesion formation following hydrolysis of urea by urease in the rat stomach
27. Helicobacter pylori increases gastric antral juxtamucosal pH
28. Chronic effect of intragastric ammonia on gastric mucosal structures in rats
29. An explanation for enhanced gastrin response to a meal in patients with Helicobacter pylori infection
30. Is there a quantifiable difference in H. pylori infection density between DU and non‐DU patients
31. Intracellular vacuolization caused by the urease of Helicobacter pylori
32. Helicobacler pylori‐induced cell vacuolalion: Cytotoxin potentiates the action of ammonia
33. Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro
34. Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 ganglioside
35. Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease
36. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens
37. Factors affecting gastric mucosal hydrophobicity in man
38. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only
39. Molecular characterization of the 128‐kDa immunodominant antigen oi Helicobacter pylori associated with cytotoxicity and duodenal ulcer
40. Cloning and expression of a high‐molecular‐mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production
41. The relationship between Helicobacter pylori and oxygen‐derived free radicals in the mechanism of duodenal ul‐ceralion
42. Helicobacter pylori: Host responses in peptic ulceration
43. Kinetics of specific IgG antibodies for monitoring the effect of anti‐Helico‐bacter pylori chemotherapy
44. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer
45. Levels of nitrite. nitrate, N‐nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach
46. Human gastric carcinogenesis: A multistep and multi‐factorial process‐First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
47. Mechanisms of endogenous nitrosation
48. Helicobacter pylori, pepsinogen and risk for gastric adenocarcinoma
49. High gastric juice ascorbic acid concentrations in members of a gastric cancer family
50. Helicobacter pylori and gastric cancer
51. Age at establishment of Heticobacter pylori infection and risk of gastric carcinoma, gastric ulcer and duodenal ulcer. A birth order and sibship size study
52. Testing for Helicobacter pylori in the diagnosis of Zollinger‐Ellison syndrome
53. An international association between Helicobacter pylori and gastric cancer
54. Extranodal lymphomas: the MALT concept
55. Heticobacler pylori‐associated gastritis and primary B‐cell gastric lym‐phoma
56. The response of cells from low‐grade B‐cell gastric lymphomas of mucosa‐associated lymphoid tissue to Helicobacter pylori
57. Healing gastric MALT lymphomas by eradicating H pylori
58. MALT‐Lymphoma Study Group, et al. Double‐blind treatment of early gastric malt‐lyn‐phoma patients by H. pylori eradication
59. Diagnosis of Helicobacter pylori infection Gastroenterol
60. Transport and storage of gastric biopsies and cultures containing Helicobacter pylori
61. Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis
62. Detection of Helicobacter pylori IgG in gingival transudate using a special collection device
63. 13C‐urea breath test for the detection of Helicobacter pylori
64. Testing for Helicobacter pylori in the diagnosis of Zollinger‐Ellison syndrome
65. Helicobacter pylori and Chronic gastritis during omeprazole long‐term treatment for duodenal ulcer
66. Changes in Helicobacter pylori associated gastritis during acid suppressive therapy
67. Duodenal ulcer treated with Helicobacter pylori eradication: Seven‐year follow‐up
68. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication
69. Patient factors affecting H. pylori eradication with triple therapy
70. Eighteen month follow up of H. pylori positive children treated with amoxycillin and tini‐dazole
71. H. pylori in children with peptic ulcer and their families
72. Optimal H. pylori therapy: A combination of omeprazole and triple therapy
73. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: A prospective, randomized, and controlled study
74. High dose om‐peprazole treatment combined with amoxycillin eradicates H. pylori
75. Dual therapy (DT) vs triple therapy (TT) for Helicobacter pylori eradication. Preliminary results of a randomized double‐blind trial
76. Clarithromycin and omeprazole for Helicobacter pylori
77. Effect of Rani‐tidine and Amoxicillin plus Metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
78. Efficacy and tolerability of a short term low dose triple therapy for eradication of Helicobacter pylori
79. Successful Helicobacter pylori eradication: A systemic effect of antibiotics
80. Bismuth plus furazoli‐done vs. Ranitidine in non ulcer dyspepsia (NUD) associated to Helicobacter pylori
81. Long term risk of peptic ulcer disease in people witb Helicobacter pylori infection ‐ a community based study
82. Eradicating Helicobacter pylori and symptoms of non‐ulcer dyspepsia
83. High recurrence rate of duodenal ulcer despite H. pylori eradication in a clinical subset ‐rapidly recurring peptic ulcer
84. Eradication of Heli‐cobacter pylori abolishes 24‐bour hypergastrinaemia: A prospective study in healthy subjects
85. Eradicating H. pylori lowers gastrin mediated acid secretion by 70% in DU patients and 50% in healthy volunteers
86. Eurogast Study Group. An internattonal association between Helicobacter pytori and gastric cancer
87. Helicobacter pylori. pepsinogen and risk for gastric adenocarcinoma
88. Levels of nitrite, nitrate. N‐nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach
89. Extranodal lymphomas: the MALT concept
90. The response of cells from low‐grade B‐cell gastric lymphomas of mucosa‐associated lymphoid tissue to Helicobacter pylori
91. Healing gastric MALT lymphomas by eradicating H pylori
92. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group